AZN:NYSE
AstraZeneca
155,82 USD
arrow_downward
−1,59%(−2,51) 1 D
158,40 USD
arrow_upward
+1,66% (+2,58)todayFør børsåpning
Stengt: 13. okt., 16:00:03 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for AZN …
Åpne
160,76 USD
Høy
160,83 USD
Lav
154,00 USD
Markedsverdi
242,43 mrd.
Snittvolum
2,91 mill.
Volum
19,44k
Utbytte
2,07 %
Kvartalsvis utbytte
0,81 USD
Første dato etter utbytte
6. aug. 2026
P/E-forhold
23,29
52 u høy
212,71 USD
52 u lav
80,48 USD
EPS
6,69 USD
Beta
0,30
Utestående aksjer
1,55 mrd.
Antall ansatte
96k
Åpne
160,76 USD
Høy
160,83 USD
Lav
154,00 USD
Markedsverdi
242,43 mrd.
Snittvolum
2,91 mill.
Volum
19,44k
Utbytte
2,07 %
Kvartalsvis utbytte
0,81 USD
Første dato etter utbytte
6. aug. 2026
P/E-forhold
23,29
52 u høy
212,71 USD
52 u lav
80,48 USD
EPS
6,69 USD
Beta
0,30
Utestående aksjer
1,55 mrd.
Antall ansatte
96k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 1 time siden
AstraZeneca reports HICKORY Phase III results for AstraZeneca stock
TipRanks
·
for 18 timer siden
AstraZeneca’s Pediatric Nexium Study Moves Toward Data Readout, Supporting Long-Term GI Franchise
ad-hoc-news.de
·
for 1 døgn siden
Jefferies keeps GBp 17,500 target for AstraZeneca stock
Kalkine Media
·
for 1 døgn siden
Can AstraZeneca (LSE:AZN) Keep Its Growth Story Intact After A Mixed Run Of Trial Readouts?
Profil
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Om AstraZeneca
Administrerende direktørPascal Soriot
Ansatte96,1k
Grunnlagt6. apr. 1999
HovedkontorCambridge, Cambridgeshire, Storbritannia
Sektor-
Nettstedastrazeneca.com